Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-3.92%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-3.92%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-426.33%
20%
—
—
Never
—
5 Years
Score—
Net Growth-426.33%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Transcode Therapeutics Inc fundamental performance
Across Transcode Therapeutics Inc's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 6M to -$ 34M. Revenue increased in 0% of the years measured; net income in 20%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.37 | — |
1 Year2025-08-12 | $ 11.51 | -70.71% |
5 Years2021-08-12 | $ 1000K | -100.00% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 |
|---|---|---|---|
| Price | $ 3.37 | $ 11.51 | $ 1000K |
| Return | — | -70.71% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 36M | $ 17.81B |
| 2025 | $ 0.00 | -$ 34M | $ 17.81B |
| 2024 | $ 0.00 | -$ 16M | $ 5M |
| 2023 | $ 0.00 | -$ 18M | $ 2M |
| 2022 | $ 0.00 | -$ 17M | $ 4M |
| IPO2021 | $ 0.00 | -$ 6M | $ 20M |
Explore beyond RNAZ
You're looking at Transcode Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
